HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity

Yi Wei Wang, Hung Shu Chang, Ching Hui Lin, Winston C Y Yu

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Several reports in the literature have indicated that the E6 not only elevates the level of c-Myc level but that the protein also associates with the Myc complex and activates Myc-responsive genes. There would seem to be a mechanism by which this oncogene can modulate cell proliferation and differentiation. Furthermore, an increase in c-Myc levels has also observed during ectopic expression of HPV E7 alone. Using the yeast two-hybrid system, we further found that the c-Myc interacts and forms a specific complex with HPV-16E7. In this study, we have demonstrated that E7 does indeed interact with c-Myc and a sequential deletion analysis of E7 maps the c-Myc interaction site to the carboxyl-terminal region. We determined two HPV-18 E7 binding sites on c-Myc involving the amino acids regions 1-100 and 367-439. The interaction of the high-risk type HPV E7 with c-Myc can augment c-Myc transactivation activity but this does not occur with low-risk type HPV E7. Deletion within the Cys-X-X-Cys repeat motif at the C-terminus of HPV-18 E7 leads to a lost of association with c-Myc and also abolishes the enhancement of c-Myc's transactivation activity. Furthermore, the interaction of HPV-18 E7 with c-Myc functionally promotes c-Myc's DNA-binding ability. Using the hTERT promoter as a model, enhanced c-Myc binding ability to the hTERT promoter as measured by immunoprecipitation assay was observed and occurred in an E7 dose-dependent manner. Taken together, these results provide significant new insights into the association of c-Myc with E7 and the possible involvement of high-risk E7 in oncogenesis.

Original languageEnglish
Pages (from-to)402-412
Number of pages11
JournalInternational Journal of Biochemistry and Cell Biology
Volume39
Issue number2
DOIs
Publication statusPublished - 2007
Externally publishedYes

Fingerprint

Human papillomavirus 18
Transcriptional Activation
Association reactions
Proto-Oncogene Proteins c-myc
Two-Hybrid System Techniques
myc Genes
Cell proliferation
Hybrid systems
Oncogenes
Immunoprecipitation
Yeast
Cell Differentiation
Assays
Carcinogenesis
Genes
Binding Sites
Cell Proliferation
Amino Acids
DNA
Proteins

Keywords

  • c-Myc
  • E7
  • Human papillomavirus
  • Telomerase
  • Transactivation

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity. / Wang, Yi Wei; Chang, Hung Shu; Lin, Ching Hui; Yu, Winston C Y.

In: International Journal of Biochemistry and Cell Biology, Vol. 39, No. 2, 2007, p. 402-412.

Research output: Contribution to journalArticle

@article{aac47a0184b745888cf8c1ddc9ff685f,
title = "HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity",
abstract = "Several reports in the literature have indicated that the E6 not only elevates the level of c-Myc level but that the protein also associates with the Myc complex and activates Myc-responsive genes. There would seem to be a mechanism by which this oncogene can modulate cell proliferation and differentiation. Furthermore, an increase in c-Myc levels has also observed during ectopic expression of HPV E7 alone. Using the yeast two-hybrid system, we further found that the c-Myc interacts and forms a specific complex with HPV-16E7. In this study, we have demonstrated that E7 does indeed interact with c-Myc and a sequential deletion analysis of E7 maps the c-Myc interaction site to the carboxyl-terminal region. We determined two HPV-18 E7 binding sites on c-Myc involving the amino acids regions 1-100 and 367-439. The interaction of the high-risk type HPV E7 with c-Myc can augment c-Myc transactivation activity but this does not occur with low-risk type HPV E7. Deletion within the Cys-X-X-Cys repeat motif at the C-terminus of HPV-18 E7 leads to a lost of association with c-Myc and also abolishes the enhancement of c-Myc's transactivation activity. Furthermore, the interaction of HPV-18 E7 with c-Myc functionally promotes c-Myc's DNA-binding ability. Using the hTERT promoter as a model, enhanced c-Myc binding ability to the hTERT promoter as measured by immunoprecipitation assay was observed and occurred in an E7 dose-dependent manner. Taken together, these results provide significant new insights into the association of c-Myc with E7 and the possible involvement of high-risk E7 in oncogenesis.",
keywords = "c-Myc, E7, Human papillomavirus, Telomerase, Transactivation",
author = "Wang, {Yi Wei} and Chang, {Hung Shu} and Lin, {Ching Hui} and Yu, {Winston C Y}",
year = "2007",
doi = "10.1016/j.biocel.2006.09.006",
language = "English",
volume = "39",
pages = "402--412",
journal = "International Journal of Biochemistry and Cell Biology",
issn = "1357-2725",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity

AU - Wang, Yi Wei

AU - Chang, Hung Shu

AU - Lin, Ching Hui

AU - Yu, Winston C Y

PY - 2007

Y1 - 2007

N2 - Several reports in the literature have indicated that the E6 not only elevates the level of c-Myc level but that the protein also associates with the Myc complex and activates Myc-responsive genes. There would seem to be a mechanism by which this oncogene can modulate cell proliferation and differentiation. Furthermore, an increase in c-Myc levels has also observed during ectopic expression of HPV E7 alone. Using the yeast two-hybrid system, we further found that the c-Myc interacts and forms a specific complex with HPV-16E7. In this study, we have demonstrated that E7 does indeed interact with c-Myc and a sequential deletion analysis of E7 maps the c-Myc interaction site to the carboxyl-terminal region. We determined two HPV-18 E7 binding sites on c-Myc involving the amino acids regions 1-100 and 367-439. The interaction of the high-risk type HPV E7 with c-Myc can augment c-Myc transactivation activity but this does not occur with low-risk type HPV E7. Deletion within the Cys-X-X-Cys repeat motif at the C-terminus of HPV-18 E7 leads to a lost of association with c-Myc and also abolishes the enhancement of c-Myc's transactivation activity. Furthermore, the interaction of HPV-18 E7 with c-Myc functionally promotes c-Myc's DNA-binding ability. Using the hTERT promoter as a model, enhanced c-Myc binding ability to the hTERT promoter as measured by immunoprecipitation assay was observed and occurred in an E7 dose-dependent manner. Taken together, these results provide significant new insights into the association of c-Myc with E7 and the possible involvement of high-risk E7 in oncogenesis.

AB - Several reports in the literature have indicated that the E6 not only elevates the level of c-Myc level but that the protein also associates with the Myc complex and activates Myc-responsive genes. There would seem to be a mechanism by which this oncogene can modulate cell proliferation and differentiation. Furthermore, an increase in c-Myc levels has also observed during ectopic expression of HPV E7 alone. Using the yeast two-hybrid system, we further found that the c-Myc interacts and forms a specific complex with HPV-16E7. In this study, we have demonstrated that E7 does indeed interact with c-Myc and a sequential deletion analysis of E7 maps the c-Myc interaction site to the carboxyl-terminal region. We determined two HPV-18 E7 binding sites on c-Myc involving the amino acids regions 1-100 and 367-439. The interaction of the high-risk type HPV E7 with c-Myc can augment c-Myc transactivation activity but this does not occur with low-risk type HPV E7. Deletion within the Cys-X-X-Cys repeat motif at the C-terminus of HPV-18 E7 leads to a lost of association with c-Myc and also abolishes the enhancement of c-Myc's transactivation activity. Furthermore, the interaction of HPV-18 E7 with c-Myc functionally promotes c-Myc's DNA-binding ability. Using the hTERT promoter as a model, enhanced c-Myc binding ability to the hTERT promoter as measured by immunoprecipitation assay was observed and occurred in an E7 dose-dependent manner. Taken together, these results provide significant new insights into the association of c-Myc with E7 and the possible involvement of high-risk E7 in oncogenesis.

KW - c-Myc

KW - E7

KW - Human papillomavirus

KW - Telomerase

KW - Transactivation

UR - http://www.scopus.com/inward/record.url?scp=33845318237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845318237&partnerID=8YFLogxK

U2 - 10.1016/j.biocel.2006.09.006

DO - 10.1016/j.biocel.2006.09.006

M3 - Article

C2 - 17070091

AN - SCOPUS:33845318237

VL - 39

SP - 402

EP - 412

JO - International Journal of Biochemistry and Cell Biology

JF - International Journal of Biochemistry and Cell Biology

SN - 1357-2725

IS - 2

ER -